共 50 条
- [2] Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis Clinical Pharmacokinetics, 2019, 58 : 1175 - 1191
- [4] Discovery of GLPG1690: A first-in-class autotaxin inhibitor in clinical development for the treatment of idiopathic pulmonary fibrosis ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251